Anaesthetic management of childhood thyrotoxicosis and the use of esmolol

Anaesthesia

Volumn 52, Issue 1, 1997, Pages 67-70

  Knighton, J D ^a   Crosse, M M ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Complications; thyrotoxicosis; Surgery; thyroidectomy; Sympathetic nervous system; pharmacology, esmolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; LUGOL; PROPRANOLOL;

ADRENERGIC SYSTEM; ARTICLE; CASE REPORT; FEMALE; HUMAN; INFANT; PEDIATRIC ANESTHESIA; PRESCHOOL CHILD; THYROID CRISIS; THYROIDECTOMY; THYROTOXICOSIS;

EID: 0031013337     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1997.t01-2-010-az010.x     Document Type: Article

References (21)

1. Foley TR Thyrotoxicosis in childhood. Paediatric Annals 1992; 21: 43-6.
2. Perrild H, Gruters-Kieslich A, Feldt-Rasmussen U, et al. Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study. European Journal of Endocrinology 1994; 131: 467-73.
3. Kopp P, Van Sande J, Parma J, et al. Brief Report: congenital hyperthyroidism caused by a mutation in the thyrotrophin- receptor gene. New England Journal of Medicine 1995; 332: 150-4.
4. Lavard L, Ranlov I, Perrild H, Anderson O, Jacobsen BB. Incidence of juvenile thyrotoxicosis in Denmark, 1982- 1988. A nationwide study. European Journal of Endocrinology 1994, 130: 565-8.
5. Caruso DR, Mazzaferri EL. Intervention in Graves' disease. Choosing among imperfect but effective treatment options. Postgraduate Medicine 1992; 92: 117-24, 128-9, 133-4.
6. Fisher DA, Graves' disease in children. Current Therapy in Endocrinology and Metabolism 1994, 5: 71-4.
7. Gross G, Lues I. Thyroid dependent alterations of myocardial adrenoceprors and adrenoceptor-mediated responses in the rat. Naunyn Schmiedbergs Archives of Pharmacology 1985; 329: 427-39.
8. Stiles GL, Lefkowitz RJ. Cardiac adrenergic receptors. Annual Review of Medicine 1984; 35: 149-64.
9. Feely J, Stevenson IH, Crooks J. Increased clearance of propranolol in thyrotoxicosis. Annals of Internal Medicine 1981; 94: 472-4.
10. Feely J, Forrest A, Gunn A, Hamilton W, Stevenson I, Crooks J. Propranolol dosage in thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism 1980; 51: 658-61.
11. Carruthers SG, Ghosal A, McDevitt DC, Nelson JK, Shanks RG. The assessment of β-adrenoceptor blocking drugs in hyperthyroidism. British Journal of Clinical Pharmacology 1974; 1: 93-8.
12. 1-blocking Agent metoprolol compared with antithyroid drug and thyroxine as preoperative treatment of patients with hyperthyroidism. Annals of Surgery 1987; 205: 182-8.
13. Kendrick AH, O'Reilly JF, Laszlo G. Lung function and exercise performance in hyperthyroidism before and after treatment. Quarterly Journal of Medicine 1988; 256: 625-7.
14. Ingbar SH. Management of emergencies IX. Thyrotoxic storm. New England Journal of Medicine 1966; 274: 1252-4.
15. Herman ML, Kuhnert L, Phythyon JM, Holaday DA. Isoflurane and enflurane-induced hepatic necrosis in triiodothyronine-pretreated rats. Anesthesiohgy 1983; 58: 1-5.
16. Trench AJ, Buckley FP, Drummond GB, Arthur GR, Scott DB. Propranolol in thyrotoxicosis. Cardiovascular changes during thyroidectomy in patients pre-treated with propranolol. Anaesthesia 1978; 33: 535-9.
17. Stocking RK, Dierdorf SF. (Compilers) Endocrine diseases. In: Anesthesia and Co-existing Disease. New York: Churchill Livingstone, 1993: 347-51.
18. Smallridge RC. Metabolic and anatomic thyroid emergencies: a review. Critical Care Medicine 1992; 20: 276- 91.
19. Thorne AC, Bedford RF. Esmolol for perioperative management of thyrotoxic goiter. Anesthesiology 1989; 71: 291-4.
20. Weist D. Esmolol: a review of its therapeutic efficacy and pharmacokinetic characteristics. Clinical Pharmacokinetics 1995; 28: 190-202.
21. Tobias JD, Tobin JR, Maxwell LG. Clinical experience with esmolol in infants. Clinical Intensive Care 1990; 1: 279-81.